Please try another search
Shares of Facebook (NASDAQ:FB) closed more than 2% lower on Monday, just two days before the company is set to report its fiscal fourth-quarter financial results. Facebook has remained a must-own...
In my 2017 Market Wrap-Up post, I referenced major support (200) and resistance (280) as levels worth monitoring on the SPX:VIX ratio, on a monthly timeframe.The following updated monthly chart of the...
On Tuesday, January 30th, Advanced Micro Devices (NASDAQ:AMD) will release its fourth quarter earnings results after the bell. The company is a Zacks Rank 3 (Hold), and have a Value, Growth, and...
A week out from Super Bowl LII in Minneapolis, with much of the football world beginning to descend upon Minnesota, businesses around the Twin Cities hope to experience an economic boost.Estimates...
The European Central Bank (ECB) kept interest rates unchanged and indicated that “they expect borrowing costs to stay at present levels until well past the end of net bond purchases.” The...
The U.S. coal industry has faced stringent environmental regulations over the last few years. However, conditions have started to change for the better after the election of the Trump administration,...
AT40 = 67.0% of stocks are trading above their respective 40-day moving averages (DMAs)AT200 = 65.2% of stocks are trading above their respective 200DMAs (a TEN MONTH HIGH)VIX = 11.1Short-term Trading...
Malaysia’s central bank, Bank Negara Malaysia, hiked its key interest rate for the first time since July 2014. The move was largely expected, as 16 out of 20 economists surveyed by Bloomberg...
Today's HighlightsDollar Bites Back Major Hack Resolved Clear Skies for Bitcoin Please note: All data, figures & graphs are valid as of January 29th. All trading carries risk. Only risk capital...
It’s perhaps the only downside to an eight-year bull market that’s still hitting new highs with no end in sight: How do you find growth in an environment like this? You could wait for one...
The all-American pharmaceutical company, Pfizer (NYSE:PFE), is looking to report its fourth-quarter and full year 2017 results next week and here are the things that you can expect from the company....
This is the week that investors love. Even though it’s not the busiest week in earnings season, with just about 400 companies reporting, it includes some of the biggest, most glamorous...
The earnings season has already started and the picture, so far, appears to be encouraging. Per the Earnings Preview dated Jan 26, nearly 133 of the S&P 500 members have reported their results....
The earnings season is off to a flying start with equity markets scaling record highs, owing to a slew of upbeat economic data, strong corporate performance and President Donald Trump's tax reform...
Novartis AG’s (NYSE:NVS) subsidiary, Advanced Accelerator Applications, obtained FDA approval for its new drug application (NDA) for Lutathera (lutetium Lu 177 dotatate) for the treatment of...